Search

Your search keyword '"Nakata, Wataru"' showing total 233 results

Search Constraints

Start Over You searched for: Author "Nakata, Wataru" Remove constraint Author: "Nakata, Wataru"
233 results on '"Nakata, Wataru"'

Search Results

1. Causal Speech Enhancement with Predicting Semantics based on Quantized Self-supervised Learning Features

2. The T05 System for The VoiceMOS Challenge 2024: Transfer Learning from Deep Image Classifier to Naturalness MOS Prediction of High-Quality Synthetic Speech

3. J-CHAT: Japanese Large-scale Spoken Dialogue Corpus for Spoken Dialogue Language Modeling

4. Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan

5. UTDUSS: UTokyo-SaruLab System for Interspeech2024 Speech Processing Using Discrete Speech Unit Challenge

6. Building speech corpus with diverse voice characteristics for its prompt-based representation

7. Coco-Nut: Corpus of Japanese Utterance and Voice Characteristics Description for Prompt-based Control

8. UTMOS: UTokyo-SaruLab System for VoiceMOS Challenge 2022

9. J-MAC: Japanese multi-speaker audiobook corpus for speech synthesis

11. Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective study

12. The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study

13. FAN score comprising fibrosis-4 index, albumin–bilirubin score and neutrophil–lymphocyte ratio is a prognostic marker of urothelial carcinoma patients treated with pembrolizumab

14. Determination of enzalutamide long-term safety and efficacy for castration-resistant prostate cancer patients after combined anti-androgen blockade followed by alternative anti-androgen therapy: a multicenter prospective DELC study

17. MO25-4 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma

18. Long-term safety and efficacy of enzalutamide for men with castration-resistant prostate cancer: a multicenter, prospective DELC study

19. This title is unavailable for guests, please login to see more information.

20. Supplementary Figure S from miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC

21. Data from miR-629 Targets TRIM33 to Promote TGFβ/Smad Signaling and Metastatic Phenotypes in ccRCC

22. A study to determine enzalutamide long term safety and efficacy for men with castration-resistant prostate cancer: A multicenter, prospective DELC study.

23. A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi‐institutional retrospective study in Japan

24. A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi‐institutional retrospective study in Japan.

30. MO24-2 Clinical outcomes of tyrosine kinase inhibitors immediately after immune checkpoint inhibitors in renal cell carcinoma

32. Usefulness of Fluorescent Urine Cytology in the Diagnosis of Urothelial Carcinoma

34. Late Recurrence of Seminoma Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration in a Retroperitoneal Lymph Node

37. Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma

40. MP14-14 CORRELATION BETWEEN IMMUNE-RELATED ADVERSE EVENTS AND CLINICAL OUTCOME IN METASTATIC RENAL CELL CARCINOMA PATIENTS TREATED WITH NIVOLUMAB: A REAL-WORLD MULTI-INSTITUTIONAL RETROSPECTIVE STUDY

46. MO27-1 Correlation between immune-related adverse events and prognosis in renal cell carcinoma patients treated with nivolumab

47. 腎外傷のため, 診断に時間を要した腎盂癌の1例

Catalog

Books, media, physical & digital resources